164 related articles for article (PubMed ID: 32350933)
1. Methylation patterns of cutaneous T-cell lymphomas.
Iżykowska K
Exp Dermatol; 2021 Aug; 30(8):1135-1140. PubMed ID: 32350933
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
5. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255
[TBL] [Abstract][Full Text] [Related]
6. Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma.
Whittaker S
J Invest Dermatol; 2016 Sep; 136(9):1753-1754. PubMed ID: 27542296
[TBL] [Abstract][Full Text] [Related]
7. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma.
Adeeb M; Therachiyil L; Moton S; Buddenkotte J; Alam MA; Uddin S; Steinhoff M; Ahmad A
Int Rev Cell Mol Biol; 2023; 380():149-171. PubMed ID: 37657857
[TBL] [Abstract][Full Text] [Related]
9. Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
Chebly A; Ropio J; Peloponese JM; Poglio S; Prochazkova-Carlotti M; Cherrier F; Ferrer J; Idrissi Y; Segal-Bendirdjian E; Chouery E; Farra C; Pham-Ledard A; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Mol Oncol; 2022 May; 16(9):1931-1946. PubMed ID: 33715271
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape of cutaneous T cell lymphoma.
Choi J; Goh G; Walradt T; Hong BS; Bunick CG; Chen K; Bjornson RD; Maman Y; Wang T; Tordoff J; Carlson K; Overton JD; Liu KJ; Lewis JM; Devine L; Barbarotta L; Foss FM; Subtil A; Vonderheid EC; Edelson RL; Schatz DG; Boggon TJ; Girardi M; Lifton RP
Nat Genet; 2015 Sep; 47(9):1011-9. PubMed ID: 26192916
[TBL] [Abstract][Full Text] [Related]
11. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma: molecular and cytogenetic findings.
Sterry W
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):13-7. PubMed ID: 17474354
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic insights into cutaneous T-cell lymphoma.
Tensen CP; Quint KD; Vermeer MH
Blood; 2022 Jan; 139(1):15-33. PubMed ID: 34570882
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
[TBL] [Abstract][Full Text] [Related]
16. Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Mishra A; La Perle K; Kwiatkowski S; Sullivan LA; Sams GH; Johns J; Curphey DP; Wen J; McConnell K; Qi J; Wong H; Russo G; Zhang J; Marcucci G; Bradner JE; Porcu P; Caligiuri MA
Cancer Discov; 2016 Sep; 6(9):986-1005. PubMed ID: 27422033
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
18. Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides.
Gallardo F; Sandoval J; Díaz-Lagares A; Garcia R; D'Altri T; González J; Alegre V; Servitje O; Crujeiras AB; Stefánsson ÓA; Espinet B; Hernández MI; Bellosillo B; Esteller M; Pujol RM; Bigas A; Espinosa L
J Invest Dermatol; 2015 Dec; 135(12):3144-3152. PubMed ID: 26302069
[TBL] [Abstract][Full Text] [Related]
19. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
Yumeen S; Girardi M
Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy and dermatologic disease: moving beyond CTCL.
Mervis JS; McGee JS
J Dermatolog Treat; 2019 Feb; 30(1):68-73. PubMed ID: 29726727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
